SpotitEarly

Company Overview

Snapshot

Founded in June 2020 by Roi Ophir, Ariel Ben Dayan, Udi Bobrovsky, and Ohad Sharon, SpotitEarly operates with 11–50 employees. The company has raised $26.5M across 3 funding rounds from 5 investors, with Hanaco Ventures participating as a lead investor. In March 2026, Fierce Healthcare recognized SpotitEarly as a "Fierce 15" Company, highlighting its innovative approach to early cancer detection.

Business overview

SpotitEarly develops a scent-based multi-cancer early detection screening test, combining a proprietary AI stack with bio-detectors to identify cancer in its early stages. The company is currently conducting a large clinical trial for screening breast, lung, colon, and prostate cancers with a single test. Operating within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Test Diagnostics & Screening, SpotitEarly serves the healthcare and life sciences markets, leveraging artificial intelligence and deep learning technologies.

Strategic signal

In January 2026, SpotitEarly announced a strategic partnership with Fox Chase Cancer Center, a move that bolsters the validity of its breakthrough early cancer detection technology. This collaboration with a prominent cancer research institution provides significant clinical validation and signals strong progress towards commercialization and broader market acceptance for its scent-based screening platform.

Company Intelligence Q&A

What is SpotitEarly's core technology?

SpotitEarly develops a scent-based multi-cancer early detection screening test that integrates a proprietary AI stack with bio-detectors to identify cancer at its early stages.

When was SpotitEarly recognized by Fierce Healthcare?

In March 2026, Fierce Healthcare named SpotitEarly a “Fierce 15” Company of 2026, acknowledging its innovative contributions to healthcare.

What strategic partnership did SpotitEarly announce in early 2026?

In January 2026, SpotitEarly announced a strategic partnership with Fox Chase Cancer Center to further validate its breakthrough early cancer detection technology.

Which investors participated in SpotitEarly's May 2025 funding round?

In May 2025, SpotitEarly raised funding from Hanaco Ventures and Menomadin Foundation.

What grant did SpotitEarly receive in January 2025?

In January 2025, SpotitEarly secured a grant from the BIRD Foundation to support its ongoing development efforts.